Continuous infusion of ketamine in hypovolemic dogs anesthetized with desflurane

Journal of Veterinary Emergency and Critical Care

Volumn 15, Issue 2, 2005, Pages 92-99

  Duque, M Juan C ^a   Souza, Almir P ^b   Nunes, Newton ^a   Honsho, Cristiane S ^a   Talieri, Ívia C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UFCG/CSTR Patos ^*  (Brazil)

Author keywords

Balanced anesthesia; Dogs; Hemodynamic; Hemorrhage

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 27644582444     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2005.00133.x     Document Type: Article

References (47)

1. Bergman SA. Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog 1999; 46:10-20.
2. Oklu E, Bulutcu FS, Yalcin Y, et al. Which anesthetic agent alters the hemodynamic status during pediatric catheterization? Comparison of propofol versus ketamine. J Cardiol Vasc Anesth 2003; 17:686-690.
3. Jacobson JD, Hartsfield SM. Cardiovascular effects of intravenous bolus administration and infusion of ketamine-midazolam in isoflurane-anesthetized dogs. Am J Vet Res 1993; 54:1715-1720.
4. Lin HC. Dissociative anesthetics, In: Thurmon JC, Tranquilli WJ, Benson GJ. eds. Lumb & Jones' Veterinary Anesthesia, 3rd edn. Philadelphia: Lea & Feabiger; 1996, pp. 241-296.
5. Haskins SC, Patz JD. Ketamine in hypovolemic dogs. Crit Care Med 1990; 18:625-629.
6. Valadão CAA, Pacchini CE. Efeitos cardiorrespiratórios da tiletamina-zolazepam em cães hipovolêmicos. Arq Bras Med Vet Zootec 2001; 53:44-51.
7. Pascoe PJ, Ilkiw JE, Haskins SC, et al. Cardiopulmonary effects of etomidate in hypovolemic dogs. Am J Vet Res 1992; 53(11): 2178-2182.
8. Ilkiw JE, Haskins SC, Patz JD. Cardiovascular and respiratory effects of thiopental administration in hypovolemic dogs. Am J Vet Res 1991; 52:576-580.
9. Haskins SC, Copland VS, Patz JD. The cardiopulmonary effects of oxymorphone in hypovolemic dogs. J Vet Emerg Crit Care 1991; 1:32-38.
10. Pascoe PJ, Haskins SC, Ilkiw JE, et al. Cardiopulmonary effects of halothane in hypovolemic dogs. Am J Vet Res 1994; 55(1):121-126.
11. Kotrly KJ, Ebert TJ, Vucins E, et al. Barorreceptor reflex control of heart rate during isoflurane anesthesia in humans. Anesthesiology 1984; 60:173-179.
12. Bernard J, Wouters PF, Doursout MF, et al. Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in the chronically instrumented dog. Anesthesiology 1990; 72:659-662.
13. Mutoh T, Nishimura R, Kim HY, et al. Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane and isoflurane, in dogs. Am J Vet Res 1997; 58:885-890.
14. Eger EI. Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC. Anesth Analg 1992; 75:3-9.
15. Pagel PS, Kampine JP, Schmeling WT, et al. Influence of volatile anesthetics on myocardial contractility in vivo: desflurane versus isoflurane. Anesthesiology 1991; 74:900-907.
16. Lutz LJ, Milde JH, Milde LN. The cerebral functional, metabolic, and hemodynamic effects of desflurane in dogs. Anesthesiology 1990; 73:125-131.
17. Clarke KW, Alibhai HIK, Lee YH, et al. Cardiopulmonary effects of desflurane in the dog during spontaneous and artificial ventilation. Res Vet Sci 1996; 61:82-86.
18. Santos PSP, Andrade JNBM, Selmi AL, et al. Cardiovascular effects of desflurane following acute hemorrhage in dogs. J Vet Emerg Crit Care 2003; 13(1):7-12.
19. Nunes N. Monitoração da anestesia, In: Fantoni DT, Cortopassi SRG. eds. Anestesia em cães e gatos. São Paulo: Roca; 2002, pp. 64-81.
20. Kaplan JA. Fisiologia cardiovascular, In: Miller RD. ed. Tratado de Anestesia. São Paulo: Manole; 1989, pp. 1189-1222.
21. Smiley RM. An overview of induction and emergence characteristics of desflurane in pediatric, adult, and geriatric patients. Anesth Analg 1992; 75(4, Suppl.):S38-S44, discussion S44-S46.
22. Hammond RA, Alibhai HIK, Walsh KP, et al. Desflurane in the dog: minimal alveolar concentration (MAC) alone and in combination with nitrous oxide. J Vet Anaesth 1994; 21(7):21-23.
23. Muir WW. Shock. Comp Cont Educ Pract 1998; 20:549-567.
24. Harrison GG. Death attributable to anaesthesia. Br J Anaesth 1978; 50:1041-1046.
25. Seyde WC, McGowan LC, Lund N, et al. Effects of anesthetics on regional hemodynamics in normovolemic and hemorrhaged rats. Am J Physiol 1985; 249:H164-H173.
26. Ingwersen W, Alien DG, Dyson DH, et al. Cardiopulmonary effects of a ketamine/acepromazine combination in hypovolemic cats. Can J Vet Res 1988; 52:423-427.
27. Schadt JC, Ludbrook JL. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol 1991; 260:H305-H318.
28. Park KW. Cardivascular effects of inhalational anesthetics. Int Anesth Clin 2002; 40:1-14.
29. Muzi M, Ebert TJ. A comparison of baroreflex sensitivity during isoflurane and desflurane anesthesia in humans. Anesthesiology 1995; 82:173-179.
30. Weiskopf RB, Moore MA, Eger EI, et al. Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans. Anesthesiology 1994; 80(5):1035-1045.
31. Pacentine GG, Muzi M, Ebert TJ. Effects of fentanyl on sympathetic activation associated with the administration of desflurane. Anesthesiology 1995; 82:823-831.
32. Muzi M, Ebert TJ, Hope WG, et al. Site(s) mediating sympathetic activation with desflurane. Anesthesiology 1996; 85: 737-747.
33. Weiskopf RB, Eger EI, Daniel M, et al. Cardiovascular stimulation induced by rapid increases in desflurane concentration in humans results from activation of tracheopulmonary and systemic receptors. Anesthesiology 1995; 83:1173-1178.
34. Milde LN, Milde JH. The cerebral and systemic hemodynamic and metabolic effects of desflurane-induced hypotension in dogs. Anesthesiology 1991; 74:513-518.
35. Guyton AC, Hall JE. Tratado de fisiologia médica, 10th edn. Rio de Janeiro, RJ: Guanabara-Koogan S.A.; 2002, pp. 136-152.
36. Kongsayreepong S, Cook DJ, Housmans PR. Mechanism of the direct, negative inotropic effect of ketamine in isolated ferret and frog ventricular myocardium. Anesthesiology 1993; 79: 313-322.
37. Cook DJ, Carton EG, Housmans PR. Mechanism of the positive inotropic effect of ketamine in isolated ferret ventricular papillary muscle. Anesthesiology 1991; 74:880-888.
38. Geliessen HP, Epema AH, Henning RH, et al. Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology 1996; 84:397-403.
39. White PF, Way WL, Trevor AJ. Ketamine - its pharmacology and therapeutic uses. Anesthesiology 1982; 56:119-136.
40. 2-adrenoceptors. Clin Exp Pharm Physiol 1997; 24:923-926.
41. Lockhart SH, Rampil IJ, Yasuda N, et al. Depression of ventilation by desflurane in humans. Anesthesiology 1991; 74:484-488.
42. McMurphy RM, Hodgson DS. Cardiopulmonary effects of desflurane in cats. Am J Vet Res 1996; 57:367-370.
43. Cournand A, Motley HL, Werko L, et al. Physiological studies of the effects of intermittent positive pressure breathing on cardiac output in man. Am J Physiol 1948; 152:162-174.
44. Morgan BC, Marten WE, Hombein TF, et al. Hemodynamic effects of intermittent positive pressure respiration. Anesthesiology 1966; 27:384-390.
45. Cullen DJ, Eger EI. Cardiovascular effects of carbon dioxide in man. Anesthesiology 1974; 41:345-349.
46. Doorley BM, Waters ST, Tennell RC, et al. MAC of I-653 in Beagle dogs and New Zealand white rabbits. Anesthesiology 1988; 69: 89-91.
47. Eger EI, Saidman LJ, Brandcaster B. Minimum alveolar concentration: a standard of anesthetic potency. Anesthesiology 1965; 26:756-763.